Open Framework Agreement On Drug Discounts In Accordance With Section 130A Paragraph 8 Sgb V With The Possibility Of Joining At Any Time So Called Approval Model 2024 09

Deadline: 05 Sep 2026

Germany

Ref. No.: 21563849

EMD:Ref Document

Bid Value: Ref Document

91 Days Left

Data Pack Assembly

Deadline: 03 Nov 2026

United States

Ref. No.: 21558837

EMD:Ref Document

Bid Value: Ref Document

150 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 21556595

EMD:Ref Document

Bid Value: Ref Document

208 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 21551066

EMD:Ref Document

Bid Value: Ref Document

208 Days Left

Open House Drug Discount Agreements For The Active Ingredient Sarilumab Atc L04Ac14

Deadline: 30 Sep 2027

Germany

Ref. No.: 21540872

EMD:Ref Document

Bid Value: Ref Document

481 Days Left

Conclusion Not Excluding Drug Discount Agreement According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Pamidronic Acid Atc Code According To Who M05Ba03

Deadline: 31 Jan 2028

Germany

Ref. No.: 21540832

EMD:Ref Document

Bid Value: Ref Document

604 Days Left

Conclusion Not Excluding Drug Discount Agreement According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Teriparatide Atc Code According To Who H05Aa02

Deadline: 31 Jan 2028

Germany

Ref. No.: 21532995

EMD:Ref Document

Bid Value: Ref Document

604 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 21511955

EMD:Ref Document

Bid Value: Ref Document

208 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Abiraterone Exclusively 500 Mg 90 Pieces Atc L02Bx03 For The Period December 1St 2025 November 30Th 2027

Deadline: 05 Oct 2027

Germany

Ref. No.: 21499594

EMD:Ref Document

Bid Value: Ref Document

486 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Aflibercept Except 114 3 Mg Ml Atc S01La05 For The Period December 1St 2025 November 30Th 2027

Deadline: 05 Oct 2027

Germany

Ref. No.: 21499070

EMD:Ref Document

Bid Value: Ref Document

486 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 21494069

EMD:Ref Document

Bid Value: Ref Document

208 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Leuprorelin Atc L02Ae02 For The Period December 1St 2025 November 30Th 2027

Deadline: 05 Oct 2027

Germany

Ref. No.: 21493659

EMD:Ref Document

Bid Value: Ref Document

486 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Doravirine Atc J05Ag06 For The Period December 1St 2025 November 30Th 2027

Deadline: 05 Oct 2027

Germany

Ref. No.: 21493157

EMD:Ref Document

Bid Value: Ref Document

486 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Doravirine Lamivudine Tenofovir Disoproxil Fumarate Atc J05Ar24 For The Period December 1St 2025 November 30Th 2027

Deadline: 05 Oct 2027

Germany

Ref. No.: 21492432

EMD:Ref Document

Bid Value: Ref Document

486 Days Left

Clinical Supervision Region S rmland And Region V stmanland

Deadline: 29 Sep 2029

Sweden

Ref. No.: 21491393

EMD:Ref Document

Bid Value: Ref Document

1211 Days Left

Discover Tenders by Non Decaffeinated Coffee Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Non Decaffeinated Coffee Sector

Filter Your Search

FREE Trial plan for all new users!